These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 7033089)
1. Effects of fully synthetic human insulin in comparison to porcine insulin in normal subjects. Schlüter KJ; Petersen KG; Borsche A; Hobitz H; Kerp L Horm Metab Res; 1981 Dec; 13(12):657-9. PubMed ID: 7033089 [TBL] [Abstract][Full Text] [Related]
2. Effects of fully synthetic human insulin in comparison to porcine insulin in normal subjects. Schlüter KJ; Petersen KG; Borsche A; Hobitz H; Kerp L Horm Metab Res; 1982 Mar; 14(3):109-11. PubMed ID: 7040195 [TBL] [Abstract][Full Text] [Related]
3. Hormonal counterregulatory responses to human (semi-synthetic and recombinant DNA) and porcine insulin induced hypoglycaemia. Owens DR; Vora JP; Tronier B; Keller U; Luzio S; Turkes A Diabetes Res; 1988 May; 8(1):17-20. PubMed ID: 3066561 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of hormonal counterregulation during GCIIS-guided hypoglycemia tests using human proinsulin and human insulin (recombinant DNA). Müller-Esch G; von der Lühe C; Ball P; Henkel E; Schlüter KJ; Wood WG; Scriba PC Horm Metab Res Suppl; 1988; 18():24-33. PubMed ID: 2847967 [TBL] [Abstract][Full Text] [Related]
5. Different potencies of biosynthetic human and purified porcine insulin. Schlüter KJ; Enzmann F; Kerp L Horm Metab Res; 1983 Jun; 15(6):271-4. PubMed ID: 6347857 [TBL] [Abstract][Full Text] [Related]
6. The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Paquot N; Scheen AJ; Franchimont P; Lefebvre PJ Diabete Metab; 1988; 14(1):31-6. PubMed ID: 3292305 [TBL] [Abstract][Full Text] [Related]
7. Comparative study of hormonal counter-regulation during GCIIS-guided insulin hypoglycemia tests using human insulin (recombinant DNA) and pork insulin. Müller-Esch G; Ball P; Bekemeyer U; Heidbüchel K; Kraas E; vd Lühe C; Tybussek R; Wood WG; Scriba PC Diabetes Res; 1985 May; 2(3):121-5. PubMed ID: 2998678 [TBL] [Abstract][Full Text] [Related]
8. Semisynthetic human insulin: pharmacokinetics and biological potency in healthy subjects in comparison with highly purified porcine insulin. Schulz B; Stöwhas H; Becker R; Steinicke A; Besch W Exp Clin Endocrinol; 1988 Mar; 92(3):307-13. PubMed ID: 3075554 [TBL] [Abstract][Full Text] [Related]
9. Counterregulatory hormone responses and symptoms during hypoglycaemia induced by porcine, human regular insulin, and Lys(B28), Pro(B29) human insulin analogue (insulin Lispro) in healthy male volunteers. Jacobs MA; Salobir B; Popp-Snijders C; Ader H; Heine RJ Diabet Med; 1997 Mar; 14(3):248-57. PubMed ID: 9088775 [TBL] [Abstract][Full Text] [Related]
10. [Biological effects of 2 different types of human insulin and monocomponent porcine insulin in normal subjects]. Lamberti C; Tarzia I; Mancini F; Di Benedetto A; De Leo A; Giunta E; Giannetti C; Cucinotta D Recenti Prog Med; 1985 Nov; 76(11):558-62. PubMed ID: 3912872 [No Abstract] [Full Text] [Related]
11. Clinical pharmacology of human insulin of recombinant DNA origin in healthy volunteers. Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Tarui S Diabetes Care; 1982; 5 Suppl 2():35-8. PubMed ID: 6765537 [TBL] [Abstract][Full Text] [Related]
12. Hypoglycemia following insulin and proinsulin. A comparison. Petersen KG; Licht T; Storch M; Pilot PR; Alexopoulos A; Lehmann M; Weigel S; Kerp L Horm Metab Res; 1986 Aug; 18(8):530-4. PubMed ID: 3530932 [TBL] [Abstract][Full Text] [Related]
13. A study of the comparative safety and efficacy of neutral soluble human (semi-synthetic) and porcine monocomponent insulin in non-diabetic subjects. Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG; Vølund A; Alberti KG; Home PD Diabete Metab; 1982 Jun; 8(2):155-8. PubMed ID: 7049781 [TBL] [Abstract][Full Text] [Related]
14. Metabolic effects of intravenous proinsulin. Petersen KG; Storch M; Schuler G; Kerp L Horm Metab Res Suppl; 1988; 18():68-73. PubMed ID: 3056815 [TBL] [Abstract][Full Text] [Related]
15. [Hormonal counterregulation following administration of human insulin and swine insulin]. Schlüter KJ; Kerp L MMW Munch Med Wochenschr; 1983 May; Suppl 1():S116-20. PubMed ID: 6408423 [No Abstract] [Full Text] [Related]
16. The clinical pharmacology of human insulin (Novo) in normal subjects. Owens DR; Jones MK; Birtwell AJ; Jones IR; Hayes TM; Heding LG Diabetes Care; 1983; 6 Suppl 1():13-6. PubMed ID: 6133710 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the counterregulatory hormone response to semisynthetic human insulin and purified porcine insulin in normal subjects and patients with type I diabetes mellitus. LeRoith D; Shemer J; Pickens W; Leslie N; Sperling M; Berelowitz M Clin Ther; 1991; 13(5):613-26. PubMed ID: 1799919 [TBL] [Abstract][Full Text] [Related]
18. Comparative clinical pharmacology of human insulin (Novo) and porcine insulin in normal subjects. Ebihara A; Kondo K; Ohashi K; Kosaka K; Kuzuya T; Matsuda A Diabetes Care; 1983; 6 Suppl 1():17-22. PubMed ID: 6343032 [TBL] [Abstract][Full Text] [Related]
19. [Biosynthetic human insulin. Pharmacokinetic characteristics and activity in normal subjects]. Brogard JM; Blickle JF; Stahl A; Pinget M; Dorner M Presse Med; 1984 Feb; 13(5):265-8. PubMed ID: 6229776 [TBL] [Abstract][Full Text] [Related]
20. Less pronounced changes in serum potassium and epinephrine during hypoglycemia induced by human insulin (recombinant DNA). Petersen KG; Schlüter KJ; Kerp L Diabetes Care; 1982; 5 Suppl 2():90-2. PubMed ID: 6765549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]